US Stock MarketDetailed Quotes

NPCE NeuroPace

Watchlist
  • 13.165
  • -0.305-2.26%
Trading May 7 12:28 ET
378.10MMarket Cap-10366P/E (TTM)

About NeuroPace Company

NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as well as depth and cortical strip leads. The firm's RNS System is designed for the treatment of medically refractory partial epilepsy and includes implantable and external products. The company was founded by Rebecca L. Kuhn, Frank M. Fischer on November 19, 1997 and is headquartered in Mountain View, CA.

Company Profile

SymbolNPCE
Company NameNeuroPace
Listing DateApr 22, 2021
Issue Price17.00
Founded1997
CEOMr. Joel Becker
MarketNASDAQ
Employees167
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address455 North Bernardo Avenue
CityMountain View
ProvinceCalifornia
CountryUnited States of America
Zip Code94043
Phone1-650-237-2700
Websitehttp://www.neuropace.com

Company Executives

  • Name
  • Position
  • Salary
  • Joel Becker
  • Director, President and Chief Executive Officer
  • 1.51M
  • Rebecca Kuhn
  • Principal Accounting Officer, Chief Financial Officer, Corporate Secretary and Vice President, Finance and Administration
  • 994.91K
  • Dr. Martha Morrell, M.D.
  • Chief Medical Officer
  • 1.11M
  • Frank M. Fischer
  • Chairman of the Board
  • 152.85K
  • Lisa Andrade
  • Independent Director
  • 125.45K
  • Dr. Uri Geiger
  • Independent Director
  • 218.80K
  • Renee Ryan
  • Independent Director
  • 124.03K
  • Rakhi Kumar
  • Independent Director
  • 126.53K
  • Joseph S. Lacob
  • Independent Director
  • 111.53K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg